These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 2789662)

  • 1. Steady state pharmacokinetics of nortriptyline in the frail elderly.
    Katz IR; Simpson GM; Jethanandani V; Cooper T; Muhly C
    Neuropsychopharmacology; 1989 Sep; 2(3):229-36. PubMed ID: 2789662
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of cytochrome P4502D6 activity with paroxetine normalizes the ultrarapid metabolizer phenotype as measured by nortriptyline pharmacokinetics and the debrisoquin test.
    Laine K; Tybring G; Härtter S; Andersson K; Svensson JO; Widén J; Bertilsson L
    Clin Pharmacol Ther; 2001 Oct; 70(4):327-35. PubMed ID: 11673748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationships among nortriptyline, 10-OH(E)nortriptyline, and 10-OH(Z)nortriptyline steady-state plasma levels and nortriptyline dosage.
    Lukey BJ; Jones DR; Wright JH; Hurst HE
    Ther Drug Monit; 1989; 11(3):221-7. PubMed ID: 2728080
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Child and adolescent nortriptyline single dose kinetics predict steady state plasma levels and suggested dose: preliminary data.
    Geller B; Cooper TB; Chestnut EC; Anker JA; Price DT; Yates E
    J Clin Psychopharmacol; 1985 Jun; 5(3):154-8. PubMed ID: 3998205
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prediction of individual dosage of nortriptyline in depressed elderly outpatients.
    Schneider LS; Cooper TB; Staples FR; Sloane RB
    J Clin Psychopharmacol; 1987 Oct; 7(5):311-4. PubMed ID: 3680600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Steady-state plasma levels of nortriptyline and its hydroxylated metabolites in Japanese patients: impact of CYP2D6 genotype on the hydroxylation of nortriptyline.
    Morita S; Shimoda K; Someya T; Yoshimura Y; Kamijima K; Kato N
    J Clin Psychopharmacol; 2000 Apr; 20(2):141-9. PubMed ID: 10770451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Electrocardiographic changes with nortriptyline and 10-hydroxynortriptyline in elderly depressed outpatients.
    Schneider LS; Cooper TB; Severson JA; Zemplenyi T; Sloane RB
    J Clin Psychopharmacol; 1988 Dec; 8(6):402-8. PubMed ID: 3069881
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Two prospective dosing methods for nortriptyline.
    Perry PJ; Browne JL; Alexander B; Tsuang MT; Sherman AD; Dunner FJ
    Clin Pharmacokinet; 1984; 9(6):555-63. PubMed ID: 6509862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nortriptyline metabolism in chronic renal failure: metabolite elimination.
    Dawling S; Lynn K; Rosser R; Braithwaite R
    Clin Pharmacol Ther; 1982 Sep; 32(3):322-9. PubMed ID: 7105623
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prediction of steady-state nortriptyline plasma levels by the repeated one-point method.
    Fant WK; Ritschel WA; Alwis SK; Roe S; Ehret J
    Clin Pharmacokinet; 1984; 9(5):450-6. PubMed ID: 6499343
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Steady-state plasma levels of E- and Z-10-OH-nortriptyline in nortriptyline-treated patients: significance of concurrent medication and the sparteine oxidation phenotype.
    Gram LF; Brøsen K; Kragh-Sørensen P; Christensen P
    Ther Drug Monit; 1989 Sep; 11(5):508-14. PubMed ID: 2815225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High plasma nortriptyline levels in the treatment of depression. I.
    Montgomery S; Braithwaite R; Dawling S; McAuley R
    Clin Pharmacol Ther; 1978 Mar; 23(3):309-14. PubMed ID: 627137
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative pharmacogenetics of nortriptyline: a novel approach.
    Kvist EE; Al-Shurbaji A; Dahl ML; Nordin C; Alván G; Ståhle L
    Clin Pharmacokinet; 2001; 40(11):869-77. PubMed ID: 11735606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship of hydroxynortriptyline to nortriptyline concentration and creatinine clearance in depressed elderly outpatients.
    Schneider LS; Cooper TB; Suckow RF; Lyness SA; Haugen C; Palmer R; Sloane RB
    J Clin Psychopharmacol; 1990 Oct; 10(5):333-7. PubMed ID: 2258449
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors influencing nortriptyline steady-state kinetics: plasma and saliva levels.
    Kragh-Sørensen P; Larsen NE
    Clin Pharmacol Ther; 1980 Dec; 28(6):796-803. PubMed ID: 7438694
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prediction of steady-state plasma levels of amitriptyline and nortriptyline from a single dose 24 hr. level in depressed patients.
    Brunswick DJ; Amsterdam J; Schless A; Rothbart M; Sandler K; Mendels J
    J Clin Psychiatry; 1980 Oct; 41(10):337-40. PubMed ID: 7430077
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nortriptyline plasma levels and therapeutic response.
    Ziegler VE; Clayton PJ; Taylor JR; Tee B; Biggs JT
    Clin Pharmacol Ther; 1976 Oct; 20(4):458-63. PubMed ID: 788992
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nortriptyline therapy in elderly patients: dosage prediction from plasma concentration at 24 hours after a single 50 mg dose.
    Dawling S; Crome P; Heyer EJ; Lewis RR
    Br J Psychiatry; 1981 Nov; 139():413-6. PubMed ID: 7332844
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nortriptyline capacity-limited metabolism: a case report.
    Browne JL; Perry PJ; Taylor JW; Sieleni BA; Kronfol Z
    J Clin Psychopharmacol; 1984 Dec; 4(6):322-5. PubMed ID: 6511999
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The kinetics of amitriptyline following single oral dose administration to man.
    Garland WA; Min BH; Birkett DJ
    Res Commun Chem Pathol Pharmacol; 1978 Dec; 22(3):475-84. PubMed ID: 734227
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.